Notice Number: NOT-FD-20-011

Key Dates
Release Date: March 11, 2020

Issued by
FOOD AND DRUG ADMINISTRATION (FDA)

Purpose

The purpose of this notice is clarify the content of the Research Strategy section to PAR-20-105 "Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed.

To allow applicants the full maximum 12 pages for the Research Strategy,

• The assessment, when applicable, must be uploaded to line item 4, Progress Report Publication List, on the PHS398 Research Plan form. Each assessment, depending on the Analytical Track, is between 1-3 pages. The page limit for the Research Strategy for each project is 12 pages.
• Facility diagrams including the location of equipment should be uploaded to line item 10. Facilities & Other Resources on the Research & Related Other Project Information form. Pictures are acceptable if they are labeled to describe the layout in the way that a diagram/sketch would. Please be mindful that any attachments must be in a PDF file format.
• Details about the major items of equipment already available for this project and pertinent capabilities should be uploaded to line item 11. Equipment on the Research & Related Other Project Information form.

Please visit www.grants.gov PAR-20-105 Laboratory Flexible Funding Model (LFFM) (U19) Clinical Trials Not Allowed Related Documents for Q&A's.

Inquiries

Please direct all inquiries to:

Kiara Fowler
Grants Management Specialist
Office of Operations, Office of Finance Budget & Acquisitions
Office of Acquisitions and Grants Services, HFA-500
U.S. Food and Drug Administration
Tel: 240-402-3099
Kiara.Fowler@fda.hhs.gov